You are here: Industry Insights > COVID-19

News List

Regeneron Begins Trials of Anti-Viral Antibody Cocktail for COVID-19 americanpharmaceuticalreview
June 22, 2020
Regeneron Pharmaceuticals announced initiation of the first clinical trial of REGN-COV2, its investigational dual antibody cocktail for the prevention and treatment of COVID-19.
Nine in 10 Americans concerned big pharma will use COVID-19 to raise drug prices europeanpharmaceuticalreview
June 22, 2020
A survey of US adults has revealed that the majority are very or somewhat worried that big pharma will take advantage of the COVID-19 pandemic to increase the price of drugs.
Clinical trial disruption from COVID-19 beginning to lessen, says report europeanpharmaceuticalreview
June 22, 2020
New findings reveal that the 200 clinical trials impacted and delayed by COVID-19 are now continuing or have completed their course.
CDRI gets approval for Phase III trial of Umifenovir to treat Covid-19 pharmaceutical-technology
June 22, 2020
Central Drug Research Institute (CDRI), a constituent lab of India-based Council of Scientific and Industrial Research (CSIR), has secured approval for carrying out Phase III trial for the use of Umifenovir in the treatment of Covid-19.
Glenmark set to get manufacturing and marketing approval for favipiravir expresspharma
June 22, 2020
Sources inform that SEC has recommended the grant of permission, along with some recommendations, the company plans to launch its product early next week.
MIS-C research can give insights on COVID-19 effect on immune system expresspharma
June 22, 2020
As multisystem inflammatory syndrome in children due to COVID-19 resemble Kawasaki disease, there is a need for longitudinal studies to determine if similar long-term complications could emerge.
Novartis stops HCQ trial against COVID-19 citing participant shortfall expresspharma
June 22, 2020
The move comes in the wake of US FDA’s decision to EUA for hydroxychloroquine and chloroquine against COVID-19.
Hetero announces launch of generic remdesivir ‘COVIFOR’ for COVID-19 treatment expresspharma
June 22, 2020
COVIFOR will be available in 100 mg vial (injectable) which has to be administered intravenously in a hospital setting under the supervision of a healthcare practitioner.
Artificial Intelligence (AI) Sector is Leveraging Their Technology to Detect Outbreaks, Enable Effective Contact Tracing and Identify Existing Drugs to Treat COVID-19 prnewswire
June 19, 2020
Artificial intelligence is being used in new ways in response to the COVID-19 pandemic. Several companies like BlueDot, IBM and BenevolentAI are leveraging their technologies to detect outbreaks.
Researchers identify potent antibody cocktail to treat COVID-19 worldpharmanews
June 19, 2020
Researchers at the University of Maryland School of Medicine (UMSOM) evaluated several human antibodies to determine the most potent combination to be mixed in a cocktail and used as a promising anti-viral therapy against the virus that causes COVID-19.